Marker Therapeutics, Inc. (MRKR)
1.45
+0.01
(+0.69%)
USD |
NASDAQ |
May 08, 09:30
Marker Therapeutics Research and Development Expense (Annual) : 11.80M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tenaya Therapeutics, Inc. | 68.61M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Neurocrine Biosciences, Inc. | 1.016B |
| Viridian Therapeutics, Inc. | 338.47M |
| electroCore, Inc. | 2.735M |